BioLineRx Ltd.

Regulatory Filings • Mar 11, 2015

_________ false

C003������� �� ��� ��"�2PublicBIOLINE RX LTD9253Corporation no: 513398750Stock Exchange/Market: NASDAQ-SC2271381����� 19 , ������� 91450 , ,Tel: 02-5489100 , 02-5489116 Fax: 02-5489101E.mail address: info@BioLineRx.comReported via MAGNA: 11/03/2015              Time of broadcast: 16:51 16:48:32

Reference: 2015-02-049105

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	BioLineRx Closes $28.75 Million Underwritten Public Offering of its American Depositary Shares

6-K_closing_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2015-02-045349     2015-02-045346     2015-02-045283
Previous names of reporting entity:
Date of revision of form structure: 09/03/2015
- - -
Name of the Signatory: : Kotler Norman Harold , Position of Signatory in the reporting corporation: General Counsel & Company Secretary , Name of Employer Company: .
Hartum Telephone: 02-5489100 , Facsimile: 02-5489101 , E-mail: normank@biolinerx.com 1